Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus.
D000368:Aged; D016588:Anticarcinogenic Agents / Q000008:administration & dosage / Q000191:economics*; D001241:Aspirin / Q000008:administration & dosage / Q000191:economics*; D001471:Barrett Esophagus / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000706:statistics & numerical data; D004938:Esophageal Neoplasms / Q000191:economics* / Q000209:etiology / Q000473:pathology / Q000517:prevention & control*; D004945:Esophagoscopy; D005260:Female; D006801:Humans; D008297:Male; D008390:Markov Chains; D008404:Massachusetts; D008875:Middle Aged; D009010:Monte Carlo Method; D012680:Sensitivity and Specificity
D016588:Anticarcinogenic Agents; D001241:Aspirin